Alphaklotholr
Alphaklotholr represents a specialized recombinant research peptide construct modeled after the extracellular domain of the anti-aging signaling protein Alpha-Klotho. Designed strictly for in vitro assays and preclinical laboratory investigations, this compound provides researchers with a targeted tool to interrogate mineral homeostasis, FGF23 co-receptor signaling, and pathways of cellular senescence.
Quick answer
Alphaklotholr represents a specialized recombinant research peptide construct modeled after the extracellular domain of the anti-aging signaling protein Alpha-Klotho. Designed strictly for in vitro assays and preclinical laboratory investigations, this compound provides researchers with a targeted tool to interrogate mineral homeostasis, FGF23 co-receptor signaling, and pathways of cellular senescence.
Key takeaways
- Alphaklotholr (Alpha-Klotho LR) is a research-grade recombinant peptide construct representing a modified or long-range functional fragment of the endogenous Alpha-Klotho protein.
- The canonical biochemical role of Alpha-Klotho revolves around its structural capacity to form a ternary complex with FGF23 and specific FGFR isoforms—predominantly FGFR1c, FGFR3c, and FGFR4.
- Beyond its role in mineral metabolism, soluble Klotho variants like alphaklotholr exhibit profound inhibitory activity against canonical and non-canonical Wnt signaling pathways.
- Renal tissue expresses the highest endogenous concentrations of Alpha-Klotho, making renal disease models a primary focus of preclinical literature.
Molecular Definition and Overview of Alphaklotholr in Laboratory Research
Alphaklotholr (Alpha-Klotho LR) is a research-grade recombinant peptide construct representing a modified or long-range functional fragment of the endogenous Alpha-Klotho protein. Investigated strictly in preclinical and in vitro laboratory settings, it functions as an essential co-receptor for fibroblast growth factor 23 (FGF23) signaling, regulating mineral homeostasis, oxidative stress pathways, and cellular senescence mechanisms.
In endogenous mammalian biology, Alpha-Klotho exists as either a single-pass transmembrane protein or a shed, soluble circulating factor. The transmembrane form acts as an obligate co-receptor for FGF23 in renal proximal and distal convoluted tubules, enabling high-affinity binding to fibroblast growth factor receptors (FGFRs). The shed, soluble form circulates systemically, acting as an endocrine protein that modulates multiple signaling cascades, including Wnt, Transforming Growth Factor-beta 1 (TGF-β1), and Insulin/IGF-1 signaling. Researchers utilizing alphaklotholr in cell culture and cell-free binding assays seek to isolate these specific enzymatic and co-receptor interactions without the confounding variables associated with full-length membrane-tethered proteins.
Primary Mechanism of Action: FGF23 Co-Receptor Complex Formation
The canonical biochemical role of Alpha-Klotho revolves around its structural capacity to form a ternary complex with FGF23 and specific FGFR isoforms—predominantly FGFR1c, FGFR3c, and FGFR4. Native FGF23 exhibits low intrinsic binding affinity for FGFRs in isolation; however, the presence of the Klotho extracellular domains (KL1 and KL2) dramatically increases binary and ternary complex stability. Preclinical binding kinetics demonstrate that alphaklotholr provides the requisite structural contact points necessary to bridge the interaction between the core receptor kinase and its circulating ligand.
In renal epithelial cell models, activation of the FGFR-Klotho signaling complex triggers downstream phosphorylation of extracellular signal-regulated kinase (ERK1/2) and early growth response 1 (EGR1). This intracellular signaling cascade ultimately results in the transcriptional downregulation of sodium-phosphate cotransporters (NaPi-2a and NaPi-2c) in the apical membrane, as well as the suppression of 1-alpha-hydroxylase (CYP27B1). Investigators employ alphaklotholr in in vitro research to precisely measure phosphate transport dynamics, calcitriol synthesis regulation, and receptor dimerization kinetics.
Antagonism of Canonical Wnt Signaling and Cellular Senescence
Beyond its role in mineral metabolism, soluble Klotho variants like alphaklotholr exhibit profound inhibitory activity against canonical and non-canonical Wnt signaling pathways. In vitro binding studies show that the sialidase-like domains within the Klotho construct directly bind to various Wnt ligands—including Wnt1, Wnt3a, Wnt4, and Wnt5a—effectively sequestering them and preventing their interaction with Frizzled receptors.
By arresting Wnt-induced beta-catenin nuclear translocation, alphaklotholr suppresses downstream target genes involved in cellular transdifferentiation and fibrogenesis. In models of cellular senescence, exposure to recombinant Klotho fragments reduces expression of the senescence-associated secretory phenotype (SASP), downregulates p21 and p16INK4a expression, and decreases intracellular reactive oxygen species (ROS) accumulation. Laboratory investigators often compare these anti-senescent outcomes with data gathered from distinct pathways using compounds like FOXO4-DRI to differentiate between direct senolytic induction and senomorphic pathway modulation.
Preclinical Investigation in Renal and Cardiovascular Models
Renal tissue expresses the highest endogenous concentrations of Alpha-Klotho, making renal disease models a primary focus of preclinical literature. In rodent models of acute kidney injury (AKI) and chronic kidney disease (CKD), exogenous administration of recombinant Klotho fragments has demonstrated a protective capacity against ischemia-reperfusion damage, unilateral ureteral obstruction (UUO) fibrosis, and diabetic nephropathy. Preclinical data indicate that alphaklotholr mitigates epithelial-to-mesenchymal transition (EMT) in tubular epithelial cells primarily through direct suppression of TGF-β1/Smad2/3 phosphorylation.
In cardiovascular research, alphaklotholr is investigated for its role in endothelial preservation and vascular calcification resistance. In vitro assays using vascular smooth muscle cells (VSMCs) cultured in high-phosphate media show that Klotho fragments prevent phosphate-induced osteogenic transdifferentiation by maintaining Runx2 suppression. Furthermore, in primary human umbilical vein endothelial cells (HUVECs), Klotho exposure stimulates endothelial nitric oxide synthase (eNOS) activation and mitigates high-glucose-induced apoptotic pathways, highlighting its utility as a molecular reference in cardiovascular biology.
Neuroprotective Potential and Central Nervous System Function
Although peripheral Klotho expression is dominated by the kidneys and parathyroid glands, the central nervous system—specifically the choroid plexus and hippocampal neurons—also maintains regulated Klotho production. Preclinical transgenic rodent studies have shown that Klotho overexpression correlates with enhanced cognitive performance, accelerated spatial learning, and resistance to neurodegenerative insults.
At the cellular level, alphaklotholr is studied for its ability to modulate N-methyl-D-aspartate (NMDA) receptor sub-unit composition. Specifically, Klotho exposure promotes the synaptic enrichment of GluN2B-containing NMDA receptors in primary hippocampal neuronal cultures, a mechanism strongly associated with enhanced long-term potentiation (LTP) and synaptic plasticity. Additionally, in vitro models of neuroinflammation demonstrate that Klotho attenuates lipopolysaccharide (LPS)-induced microglial activation and downregulates pro-inflammatory cytokine production (TNF-alpha, IL-6), providing a valuable mechanism for neuroprotective research.
Comparative Analysis: Alphaklotholr vs. Other Longevity Research Compounds
When designing preclinical protocols focused on cellular longevity, metabolic regulation, and anti-aging signaling pathways, laboratory researchers frequently evaluate alphaklotholr alongside other established research peptides. Each class operates through distinct, non-overlapping biochemical targets, offering unique vantage points for mechanistic studies.
While alphaklotholr functions primarily as an FGFR co-receptor and extracellular signaling antagonist (suppressing Wnt and TGF-beta cascades), telomerase activators like Epitalon target chromatin structure and telomerase reverse transcriptase (TERT) expression. Concurrently, extracellular matrix-modulating peptides such as GHK-Cu regulate gene expression profiles linked to tissue remodeling, whereas mitochondrial-derived peptides like MOTS-c and cardiolipin-targeting compounds like SS-31 act directly on intracellular energetic pathways and mitochondrial ROS generation. Comparing these agents across parallel cell lines allows investigators to map comprehensive pathway interactions across different organellar and extracellular domains.
Laboratory Handling, Reconstitution, and Storage Protocols
Proper handling and storage protocols are paramount to maintaining the structural integrity and biological activity of recombinant peptide constructs such as alphaklotholr. Supplied as a lyophilized powder, the compound should be stored at -20°C or -80°C upon receipt to prevent thermal degradation and non-specific aggregation.
Reconstitution should be performed under sterile laminar flow conditions using non-pyrogenic sterile water or phosphate-buffered saline (PBS, pH 7.4). To minimize non-specific adsorption of the peptide to container walls, researchers frequently reconstitute the compound in a buffer containing 0.1% purified bovine serum albumin (BSA) or human serum albumin (HSA). Following initial solubilization, the solution should be gently agitated without vortexing, aliquoted into single-use polypropylene microcentrifuge tubes, and stored at -80°C. Repeated freeze-thaw cycles must be strictly avoided as they induce protein unfolding and loss of receptor-binding affinity.
Analytical Quality Control, Purity Verification, and Supplier Standards
Preclinical and in vitro research relies entirely on the chemical purity and structural fidelity of experimental compounds. Contaminants such as residual host-cell proteins, organic solvents, or bacterial endotoxins can introduce significant artifacts into cell culture assays, masking true biochemical responses or inducing non-specific inflammatory pathways.
At PX1 Research, every batch of alphaklotholr undergoes rigorous analytical verification prior to release. Purity is characterized using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a minimum purity standard of >98%. Molecular mass and amino acid sequence identity are confirmed via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) or Electrospray Ionization Mass Spectrometry (ESI-MS). Furthermore, all products are manufactured in USA-based, ISO 17025 accredited and GMP-compliant facilities, and undergo chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain below strictly defined laboratory limits (<0.01 EU/µg). Researchers can examine batch-specific data via our public Certificate of Analysis repository or explore high-volume options through our wholesale lab account portal across our complete catalog of research peptides.
Frequently Asked Questions
What is alphaklotholr and what is its primary use in laboratory research?
Alphaklotholr is a research-grade recombinant peptide construct modeled after the functional domains of the Alpha-Klotho protein. It is utilized exclusively in laboratory settings to investigate mineral homeostasis, FGF23 co-receptor dynamics, Wnt pathway inhibition, and cellular senescence mechanisms.
How does alphaklotholr differ from full-length transmembrane Alpha-Klotho?
Full-length Alpha-Klotho is a single-pass transmembrane protein anchored to the plasma membrane, primarily in renal tubules. Alphaklotholr represents a soluble, unanchored recombinant fragment that mimics shed, circulating Klotho, enabling in vitro research into endocrine signaling without membrane-tethered constraints.
What reconstituted carrier buffer is recommended for alphaklotholr?
Reconstitution in sterile PBS (pH 7.4) supplemented with 0.1% carrier protein (such as research-grade BSA or HSA) is recommended to prevent non-specific peptide binding to plastic tube walls and culture vessels.
Why is endotoxin testing critical when sourcing alphaklotholr for cell culture?
Bacterial endotoxins (LPS) can trigger Toll-like receptor 4 (TLR4) activation in cell cultures, causing non-specific inflammatory cytokine release. PX1 Research tests every batch using LAL assays (<0.01 EU/µg) to ensure cell signaling data reflects pure compound activity.
How does alphaklotholr modulate Wnt signaling in vitro?
Preclinical data show that the extracellular domains of Klotho directly bind and sequester Wnt ligands (e.g., Wnt1, Wnt3a), preventing Frizzled receptor activation and inhibiting beta-catenin nuclear translocation.
What are the proper long-term storage conditions for lyophilized alphaklotholr?
Lyophilized alphaklotholr should be stored at -20°C or -80°C in a desiccated environment. Reconstituted stock solutions should be aliquoted to avoid freeze-thaw cycles and stored at -80°C.
Can alphaklotholr be studied alongside other anti-aging research peptides?
Yes. Researchers frequently benchmark alphaklotholr against other longevity models—such as Epitalon (telomerase activity), GHK-Cu (gene modulation), or MOTS-c (mitochondrial signaling)—to delineate pathway-specific mechanisms.
How does PX1 Research verify the identity and purity of alphaklotholr?
PX1 Research verifies every lot using RP-HPLC for purity (>98%) and Mass Spectrometry (MS) for sequence and molecular weight confirmation. Lot-specific Certificates of Analysis (COAs) are made available for every purchase.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.